Biomarkers for dementia vary with time of day

A research team led by the University of Surrey has found that the biomarkers used to diagnose Alzheimer’s, including a promising marker for early diagnosis of the condition, vary significantly depending on the time of day they are taken. Biomarker levels were at their lowest in the morning when participants woke and highest in the evening.

The study looked at 38 participants living with mild Alzheimer’s, their caregivers and health controls while they were residents at the Surrey Sleep Research Centre, which is part of the UK Dementia Research Institute Care Research & Technology Centre. Instead of taking one blood sample, as is the case in the majority of clinical practices, the participants had their blood taken every three hours for 24 hours.

Four out of five measured biomarkers (p-tau217, Aβ40, Aβ42, and NfL) showed levels of fluctuation throughout the day; only GFAP did not show a statistically significant variation. The biomarker p-tau217, which could help with early diagnosis of dementia, showed particularly big differences, with the researchers finding the variation between morning and evening levels was similar to the changes seen in people whose mild memory problems get worse over a year. The results were published in the journal Translational Psychiatry.

It is not known what is driving these time-of-day differences. It may relate to sleep and sleep-related reduction in the production or clearance of these markers from the brain to the circulation, meals, posture, activity or circadian mechanisms. Nevertheless, the findings suggest that the time of day of sample collection is relevant in the implementation and interpretation of plasma biomarkers in dementia research and care, and that the time of sampling should be standardised or at least recorded.

“This work shows the importance of considering the time of day when taking clinical diagnostic samples and how the clinical picture for an individual may be affected by varying sample times,” said Dr Ciro della Monica, a Research Fellow at the Surrey Sleep Research Centre. “By standardising the time of day that a sample is taken, the diagnosis of dementia and tracking disease progression can become more accurate.”

“Circadian rhythm research has demonstrated that almost all variables related to physiology and brain function vary with the time of day,” added Professor Derk-Jan Dijk, Director of the Surrey Sleep Research Centre. “This study shows that translating this basic knowledge to the area of dementia research holds great promise for a better understanding, diagnosis and treatment of Alzheimer’s.”

Image credit: iStock.com/aquaArts studio